IndiaTickerLatest filing: Mangalam Drugs & Organics Ltd - 532637 - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
ObservedCompany dossier
Mangalam Drugs & Organics
NSE:MANGALAM · ISIN INE584F01014
- Close
- ₹27.14 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Mangalam Drugs & Organics
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹88.7 Cr · PAT ₹1.3 Cr.
Exchange XBRLLatest ownership: promoter group 35.65% and public 64.35% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Mangalam Drugs & Organics Ltd - 532637 - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
BSE · exchange filing
Observed
Archived filing Fraud/Default/Arrest - Mangalam Drugs And Organics Limited
NSE · exchange filing
Observed
Archived filing Defaults on Payment of Interest/Principal - Mangalam Drugs And Organics Limited
NSE · exchange filing
Observed
Source filing Mangalam Drugs & Organics Ltd - 532637 - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹88.7 Cr
- Profit after tax
- ₹1.3 Cr
- EPS
- ₹0.81
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 35.65%
- Public
- 64.35%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL